A new delivery system for bacteriophages—viruses that selectively attack harmful bacteria—could help give doctors a new way to battle lung infections that threaten older patients and people with cystic fibrosis.
Biotechnology
Jul 17, 2018
0
32
A study of cystic fibrosis patients finds new evidence that infected bacteria lower resistance to antibiotics as they become 'more comfortable' in the body
Cell & Microbiology
Jul 6, 2018
0
3
Cystic fibrosis patients have a wide variety of bacteria in their lungs, including two 'predators' not detected before, according to a new study of lung microorganisms published this week in mBio, an online open-access journal ...
Cell & Microbiology
Sep 26, 2017
0
16
New lung "organoids"—tiny 3-D structures that mimic features of a full-sized lung—have been created from human pluripotent stem cells by researchers at Columbia University Medical Center (CUMC). The team used the organoids ...
Cell & Microbiology
May 12, 2017
0
201
(Phys.org)—A team of researchers from multiple institutions in the U.S. has developed a new way to treat lung disease—using nanoparticles to transport chemicals through the thick mucus membranes that can coat pulmonary ...
Scientists from the University of Liverpool's Institute of Infection and Global Health have shown that phage therapy could offer a safe and effective alternative to antibitotics in the treatment of cystic fibrosis lung infections.
Cell & Microbiology
Mar 13, 2017
5
115
The chronic lung inflammation that is a hallmark of cystic fibrosis, has, for the first time, been linked to a new class of bacterial enzymes that hijack the patient's immune response and prevent the body from calling off ...
Cell & Microbiology
Dec 12, 2016
0
17
The bacterium Pseudomonas aeruginosa is a life-threatening pathogen in hospitals. About ten percent of all nosocomial infections, in particular pneumonia, are caused by this pathogen. Researchers from the University of Basel's ...
Cell & Microbiology
Oct 24, 2016
0
11
A scientist from the PETA International Science Consortium Ltd. is the lead author of a review on pulmonary fibrosis that results from inhaling nanomaterials, which has been published in Archives of Toxicology. The coauthors ...
Bio & Medicine
May 26, 2016
0
23
Most people in the developing world who have asthma, cystic fibrosis or other chronic lung diseases have no way to measure how well their lungs are functioning outside of a clinic or doctor visit.
Engineering
May 2, 2016
0
319
